Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The closing price of Glaukos Corporation (NYSE: GKOS) was $97.19 for the day, up 2.50% from the previous closing price of $94.82. In other words, the price has increased by $2.50 from its previous closing price. On the day, 0.86 million shares were traded.
Ratios:
Our analysis of GKOS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.62 and its Current Ratio is at 6.49. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.14.
On February 19, 2025, Mizuho Upgraded its rating to Outperform which previously was Neutral and also upped its target price recommendation from $140 to $200.
Citigroup Upgraded its Neutral to Buy on December 11, 2024, whereas the target price for the stock was revised from $132 to $162.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 25 ’25 when Thurman Alex R. sold 1,520 shares for $106.84 per share. The transaction valued at 162,399 led to the insider holds 53,431 shares of the business.
Thurman Alex R. bought 1,520 shares of GKOS for $162,402 on Mar 25 ’25. On Feb 26 ’25, another insider, Foley Mark J, who serves as the Director of the company, sold 20,687 shares for $120.72 each. As a result, the insider received 2,497,335 and left with 54,249 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 13.73 while its Price-to-Book (P/B) ratio in mrq is 7.22.
Stock Price History:
Over the past 52 weeks, GKOS has reached a high of $163.71, while it has fallen to a 52-week low of $77.10. The 50-Day Moving Average of the stock is 3.09%, while the 200-Day Moving Average is calculated to be -22.74%.
Shares Statistics:
A total of 56.74M shares are outstanding, with a floating share count of 55.03M. Insiders hold about 3.69% of the company’s shares, while institutions hold 100.85% stake in the company.
Earnings Estimates
As of right now, 15.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.23, with high estimates of -$0.15 and low estimates of -$0.31.
Analysts are recommending an EPS of between -$0.63 and -$1.18 for the fiscal current year, implying an average EPS of -$0.86. EPS for the following year is $0.03, with 15.0 analysts recommending between $0.64 and -$0.68.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 14 analysts. It ranges from a high estimate of $117.44M to a low estimate of $113.2M. As of the current estimate, Glaukos Corporation’s year-ago sales were $95.69MFor the next quarter, 14 analysts are estimating revenue of $120.49M. There is a high estimate of $124.35M for the next quarter, whereas the lowest estimate is $117M.
A total of 15 analysts have provided revenue estimates for GKOS’s current fiscal year. The highest revenue estimate was $483.7M, while the lowest revenue estimate was $477.71M, resulting in an average revenue estimate of $480.78M. In the same quarter a year ago, actual revenue was $383.48MBased on 15 analysts’ estimates, the company’s revenue will be $613.51M in the next fiscal year. The high estimate is $674.7M and the low estimate is $577.35M.
